| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 5.50 | 0.02 (+0.38%) | 3.95 - 9.28 | 98.3 thousand (Below Avg) |
Market data as of 12:12PM 05/21/13. Quotes are delayed by at least 15 min.
| Open | 5.48 |
|---|---|
| Previous Close | 5.48 |
| Day's Range | 5.45 - 5.60 |
| Market Cap | 311.1M |
| Avg Volume (10 Day) | 742.6K |
| Price/Earnings (Trailing 12 Mo.) | 14.8x |
| Earnings Per Share (Trailing 12 Mo.) | 0.37 |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Fail |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Neutral |
| Increased shareholder value? | Neutral |
| Consistently increased owner earnings? | Fail |
| Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Fail |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Pass |
| Borrows within reasonable limits? | Neutral |
| Stock is undervalued? | Pass |
| Have investors caught on? | Fail |
| Has support of institutional investors? | Pass |
| Has sufficient liquidity? | Pass |
No news headlines available for THLD
| THLD | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | 2,618.79% | |
| Net Income Growth (1yr) | -- | |
| Total Debt/Equity | -- | |
| LT Debt/Equity | -- | |
| Earnings Yield | 6.76% | |
| Price/Sales | 36.30 |
| Company | Last | Change |
|---|---|---|
| Vical Inc | 3.65 | +1.11% |
| Curis Inc | 3.86 | -1.28% |
| Novavax Inc | 1.98 | +0.01% |
| Repros Therapeutics Inc | 15.70 | -0.24% |
| Coronado Biosciences Inc | 10.03 | -1.62% |
Data is delayed by at least 15 min.